NCT02069379View on ClinicalTrials.gov

Endogenous Opioid Activity and Affective State in Insulin Resistant Women

PHASE4CompletedINTERVENTIONAL
Enrollment

42

Participants

Timeline

Start Date

July 31, 2014

Primary Completion Date

March 24, 2017

Study Completion Date

September 30, 2017

Conditions
DepressionInsulin ResistanceMetabolic Syndrome
Interventions
DRUG

Metformin

Women classified as insulin resistant will participate in both a placebo and a metformin treatment arm, each lasting about 16 weeks. Women will be randomized to order of treatment arms.

DRUG

Placebo

Placebo capsules prepared identically to Metformin capsules

Trial Locations (1)

48103

University of Michigan Medical School, Ann Arbor

All Listed Sponsors
collaborator

National Institute of Mental Health (NIMH)

NIH

lead

University of Michigan

OTHER

NCT02069379 - Endogenous Opioid Activity and Affective State in Insulin Resistant Women | Biotech Hunter | Biotech Hunter